In early 2026, Moderna reported encouraging long-term data for its personalized cancer vaccine mRNA-4157 (V940) in high-risk melanoma, while the FDA granted expedited review and an August 5, 2026 ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Researchers boosted levels of a heart-healing hormone in mice and pigs with a single injection of a new, experimental form of ...

Next Conyngham used Grok to design an mRNA vaccine that boosts the production of tumor-associated antigens enabling Rosie's ...

Messenger RNA (mRNA) therapeutics have moved from a promising idea to clinical reality, accelerating vaccine development and opening new paths ...

Better mRNA release inside cells boosts vaccine and gene editing performance, enabled by redesigned lipid molecules that grip ...

A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, the Washington Post reported on ...

In the latest trading session, Moderna (MRNA) closed at $51.38, marking a -1.89% move from the previous day. This change lagged the S&P 500's daily loss of 1.51%. On the other hand, the Dow registered ...

ALBANY, NY (News10) – Six years ago this month, New York declared a state of emergency due to covid-19. With the pandemic, the use of mRNA technology for vaccines became more mainstream. At UAlbany, ...

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

AI-driven tumor immunity mapping could improve mRNA vaccine design, delivery, and personalization in oncology. Read more.